Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
Kulke MH, Bergsland EK, Ryan DP, Enzinger PC, Lynch TJ, Zhu AX, Meyerhardt JA, Heymach JV, Fogler WE, Sidor C, Michelini A, Kinsella K, Venook AP, Fuchs CS.
Kulke MH, et al. Among authors: lynch tj.
J Clin Oncol. 2006 Aug 1;24(22):3555-61. doi: 10.1200/JCO.2006.05.6762.
J Clin Oncol. 2006.
PMID: 16877721
Clinical Trial.